Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 22:9:934946.
doi: 10.3389/fcvm.2022.934946. eCollection 2022.

Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors

Affiliations

Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors

Andreas S Papazoglou et al. Front Cardiovasc Med. .

Abstract

Background: Routine coronary artery disease (CAD) secondary prevention strategies target standard modifiable cardiovascular risk factors (SMuRFs), which include: diabetes mellitus, dyslipidemia, hypertension, and smoking. However, a significant proportion of patients with acute coronary syndrome (ACS) present without any SMuRFs. The angiographic severity of disease in this population has not yet been investigated.

Methods: After propensity score matching of patients without SMuRFs and patients with ≥1 SMuRFs (ratio 1:3), we used zero-inflated negative binomial regression modeling to investigate the relationship of SMuRF-less status with the angiographic severity of CAD, as measured by the SYNTAX score. Survival analysis was performed to investigate differences in all-cause mortality at 30 days and at the end of follow-up period.

Results: We analyzed 534 patients presenting with ACS who underwent coronary angiography. Of them, 56 (10.5%) presented without any SMuRF. After propensity score matching, the median SYNTAX score was 13.8 (IQR 0-22.1) in 56 SMuRF-less patients and 14 (IQR 5-25) in 166 patients with ≥1 SMuRFs. SMuRF-less status was associated with increased odds of zero SYNTAX score [zero-part model: odds ratio = 2.11, 95% confidence interval (CI): 1.03-4.33], but not with decreased SYNTAX score among patients with non-zero SYNTAX score (count-part model: incidence rate ratio = 0.99, 95% CI: 0.79-1.24); the overall distribution of the SYNTAX score was similar between the two groups (p = 0.26). The 30-day risk for all-cause mortality was higher for SMuRF-less patients compared to patients with ≥1 SMuRFs [hazard ratio (HR) = 3.58, 95% CI: 1.30-9.88]; however, the all-cause mortality risk was not different between the two groups over a median 1.7-year follow-up (HR = 1.72, 95% CI: 0.83-3.57).

Conclusion: Among patients with ACS, the absence of SMuRFs is associated with increased odds for non-obstructive CAD and with increased short-term mortality rates.

Keywords: SYNTAX score; acute coronary syndrome; angiographic severity; myocardial infarction; standard modifiable cardiovascular disease risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
SYNTAX score distribution by the presence of SMuRFs. (A) The boxplots depict almost equal median SYNTAX score among patients with and without SMuRFs. (B) The histogram indicates the higher proportion of zero SYNTAX score in SMuRF-less patients. SMuRF, standard modifiable risk factors.
FIGURE 2
FIGURE 2
Kaplan–Meier curves depending on the presence of SMuRFs for: (A) 30-day all-cause mortality rates, (B) long-term all-cause mortality rates. SMuRF-less patients had significantly higher incidence of 30-day all-cause mortality; however, long-term mortality rates did not differ significantly among patients with and without SMuRFs. Both survival analyses included 206/224 matched participants since follow-up data were not available for the remaining ones.

Similar articles

Cited by

References

    1. WHO. CVD Atlas: Cardiovascular Diseases. Geneva: WHO; (2021).
    1. Chen X, Liu HX, Yu XQ, Yang SQ, Qi LY, Cai L. Standard modifiable cardiovascular risk factors and prognosis of acute coronary syndrome in younger patients. J Coll Phys Surg Pak. (2021) 31:1394–8. 10.29271/jp.2021.12.1394 - DOI - PubMed
    1. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. (2020) 395:795–808. 10.1016/S0140-6736(19)32008-2 - DOI - PMC - PubMed
    1. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. (2021) 42:3227–37. 10.1093/eurheartj/ehab484 - DOI - PubMed
    1. Vernon ST, Coffey S, D’Souza M, Chow CK, Kilian J, Hyun K, et al. ST-Segment–Elevation Myocardial Infarction (STEMI) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their outcomes? J Am Heart Assoc. (2019) 8:e013296. 10.1161/JAHA.119.013296 - DOI - PMC - PubMed